Protection through Biontech vaccination: manuscript brings cautious hope


So far there has only been knowledge to what extent the agent protects against diseases.  The  active ingredient is “highly effective” in preventing infections with SARS-CoV-2, according to a manuscript for a study by the two manufacturers together with the Israeli Ministry of Health.

Researchers advise caution

However, the study authors also write that their approach could lead to the effect of vaccination on infections being overestimated. © The  study results are difficult to assess. © The  manuscript was leaked to Israeli journalists from the internet portal “ynet” and has not been officially published, neither on a preprint server nor in a specialist journal that has been examined by experts. Biontech did not want to comment on the document when asked on Sunday. © The  S manuscript is based on Israeli health records of vaccinated and unvaccinated people.

So far it was unclear to what extent the vaccine from Biontech / Pfizer prevents infections with the coronavirus. Because the first results of a large clinical investigation with more than 40,000 test persons did not refer to infections, but to diseases.

According to this early study, the Biontech vaccine was 95 percent effective on disease. This means that 95 percent fewer diseases occurred among the subjects in a vaccinated group than among those in a control group. In order to get the pandemic under control as quickly as possible, not only diseases should be prevented, but chains of infection should also be broken.



info Click on the icon to add the keyword to your topics.


Click on the icon to open your “my topics” page. © The y have of 15 keywords saved and would have to remove keywords.


info With a click on the icon you remove the keyword from your topics.


Add the subject to your subjects.

[ source link ];art17,3355491

Protection Biontech vaccination manuscript brings cautious hope


Please enter your comment!
Please enter your name here